Cleared Traditional

K852249 - KONTRON VITALMON 5010 PATIENT MONITOR

K852249 is an FDA 510(k) clearance for KONTRON VITALMON 5010 PATIENT MONITOR, manufactured by Kontron Instruments, Inc.. The device is a Class 2 Anesthesiology device with product code BZQ cleared through the Traditional 510(k) pathway after a 511-day FDA review.

K852249 · Kontron Instruments, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1986
Decision
511d
Days
Class 2
Risk

K852249 is an FDA 510(k) clearance for the KONTRON VITALMON 5010 PATIENT MONITOR. Classified as Monitor, Breathing Frequency (product code BZQ), Class II - Special Controls.

Submitted by Kontron Instruments, Inc. (Everett, US). The FDA issued a Cleared decision on October 16, 1986 after a review of 511 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2375 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Kontron Instruments, Inc. devices

FDA 510(k) Submission Details - K852249

510(k) Number K852249 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 1985
Decision Date October 16, 1986
Days to Decision 511 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
371d slower than avg
Panel avg: 140d · This submission: 511d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BZQ Device Classification - Class 2, Special Controls

Product Code BZQ Monitor, Breathing Frequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2375
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZQ Monitor, Breathing Frequency

All 67
Devices cleared under the same product code (BZQ) and FDA review panel - the closest regulatory comparables to K852249.
MODEL 500E INFANT MONITORING SYSTEM
K873791 · Ge Medical Systems Information Technologies · Nov 1987
LIFEWATCH PLUS
K870661 · The Perkin-Elmer Corp. · Mar 1987
LIFESCOPE 6, OEC-6120 PORTABLE PATIENT MONITOR REC
K862462 · Nihon Kohden America, Inc. · Feb 1987
MONAGHAN RVM, MODEL 760 AND 761
K863612 · Monaghan Medical Corp. · Oct 1986
BIOCHEM 515 RESPIRATION MONITOR
K854333 · Biochem International, Inc. · May 1986
INFANT MONITOR
K861484 · Healthdyne, Inc. · May 1986